Artificial Intelligence in Urological Oncology: Applications in Imaging, Prognostics, and Precision Disease Management
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 127
Special Issue Editor
Special Issue Information
Dear Colleagues,
Artificial intelligence (AI) is rapidly transforming the field of urological oncology, offering novel opportunities to improve diagnosis, risk stratification, and disease management, including treatment selection and follow-up of patients. Advances in imaging, digital pathology, molecular profiling, and clinical decision support systems are driving more precise prognostication and individualized patient management. Beyond diagnostics and prognostics, AI applications are increasingly shaping therapeutic decision-making, surveillance strategies, and real-world patient care.
This Special Issue aims to bring together cutting-edge research and expert reviews highlighting the role of AI across the continuum of urological cancer care. We welcome contributions that showcase innovative methodologies, clinical applications, translational insights, and critical perspectives on the integration of AI into daily practice.
Prof. Dr. S. D. Brookman-May
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- machine learning
- urological oncology
- imaging, precision medicine
- digital pathology
- therapeutic decision-making
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
